{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:19:10Z","timestamp":1794374350952,"version":"4.9.0"},"reference-count":192,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100008530","name":"european regional development fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ther Adv Neurol Disord"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:p>The development and successful clinical application of engineered T cells expressing synthetic chimeric antigen receptors (CARs) represents a milestone in cancer therapy. This approach optimizes physiological in vivo T-cell activation against specific target antigens expressed on defined cell subsets with the goal of their deep and sustained depletion. Significant progress has been made in redesigning CAR T-cell constructs to improve patient safety, therapeutic efficacy, and accessibility. Efforts have also focused on streamlining manufacturing to improve availability and reduce costs, two critical challenges to widespread adoption. Beyond hematologic malignancies, CAR T-cell therapies are now increasingly being repurposed to tackle B-cell-mediated autoimmune diseases (AIDs). This is primarily achieved through broad B-cell depletion, but more targeted approaches\u2014such as the selective elimination of autoantibody-producing B-cell subpopulations\u2014are also being explored. Important considerations in their implementation are identifying the most pertinent patient groups, tailoring their treatment up to the point of CAR-infusion, and following up on their unique toxicity-profile. In the context of neurological AIDs\u2014including refractory myasthenia gravis, Lambert\u2013Eaton syndrome, multiple sclerosis, and stiff-person syndrome\u2014early clinical experience suggests promising efficacy and tolerability, leading to a growing number of registered clinical trials. In this review, we provide an overview of the mechanism and evolution of CAR T-cell therapy, highlighting why its application in AIDs, particularly in neurology, represents a highly promising therapeutic strategy.<\/jats:p>","DOI":"10.1177\/17562864251396039","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T10:07:48Z","timestamp":1765361268000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":7,"title":["CAR T-cell therapy for neurological disorders: scientific rationale and mechanistic insights"],"prefix":"10.1177","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4886-4540","authenticated-orcid":false,"given":"Dimitrios E.","family":"Katsaros","sequence":"first","affiliation":[{"name":"Department of Hematology, Oncology, and Cell Therapy, Otto-von-Guericke University Magdeburg, Magdeburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2817-6660","authenticated-orcid":false,"given":"Dimitrios","family":"Mougiakakos","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oncology, and Cell Therapy, Otto-von-Guericke University Magdeburg, Leipziger Str. 44, Magdeburg 39120, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00459-7"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.10.017"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707447"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-769620"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-05707-3"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2023.06.002"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024025413"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01278-3"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00194-1"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(23)00375-7"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/s44321-024-00043-z"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlife.2024.05.005"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2024.03.002"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2024.04.014"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2403227121"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-024-12367-4"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200292"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101794"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2024-226017"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000212220"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2025.100704"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2025.03.018"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(25)00199-1"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2025.100776"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197905103001902"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.134939"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01115-0"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-042617-053429"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.3390\/biology12091163"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201966"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.2.781"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-024-02226-y"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01687-8"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-022-00371-7"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.886546"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2303379"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-129600"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024024104"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-203279"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.3390\/cells9051182"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.24.10024"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.03.014"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4597"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30277-5"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04372-4"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2016.01.021"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aat6753"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-14-0186"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.omto.2019.08.002"},{"key":"e_1_3_4_51_2","unstructured":"Havert M. Summary basis for regulatory action: axicabtagene ciloleucel. U.S. Food & Drug Administration https:\/\/www.fda.gov\/files\/vaccines%2C%20blood%20%26%20biologics\/published\/October-18\u20132017-Summary-Basis-for-Regulatory-Action\u2014YESCARTA.pdf (2017 accessed 11 August 2025)."},{"key":"e_1_3_4_52_2","unstructured":"Liu XV. Summary basis for regulatory action: tisagenlecleucel. U.S. Food & Drug Administration https:\/\/www.fda.gov\/files\/vaccines%2C%20blood%20%26%20biologics\/published\/August-3 (2017 accessed 11 August 2025)."},{"key":"e_1_3_4_53_2","unstructured":"Price G. Summary basis for regulatory action: brexucabtagene autoleucel. U.S. Food & Drug Administration https:\/\/www.fda.gov\/media\/141093\/download (2020 accessed 11 August 2025)."},{"key":"e_1_3_4_54_2","unstructured":"Kwilas A. Summary basis for regulatory action: idecabtagene vicleucel https:\/\/fda.report\/media\/147627\/Summary+Basis+for+Regulatory+Action+-+ABECMA.pdf. (2021 accessed 11 August 2025)."},{"key":"e_1_3_4_55_2","unstructured":"Schultz KLW. Summary basis for regulatory action: lisocabtagene maraleucel https:\/\/fda.report\/media\/146242\/Summary+Basis+for+Regulatory+Action+-+BREYANZI.pdf (2021 accessed 11 August 2025)."},{"key":"e_1_3_4_56_2","unstructured":"Ye Z. Summary basis for regulatory action: ciltacabtagene autoleucel. U.S. Food & Drug Administration https:\/\/www.fda.gov\/media\/156999\/download (2022 accessed 11 August 2025)."},{"key":"e_1_3_4_57_2","unstructured":"Timmons A. Summary basis for regulatory action\u2014AUCATZYL (obecabtagene autoleucel). U.S. Food and Drug Administration https:\/\/www.fda.gov\/media\/183887\/download (2024 accessed 11 August 2025)."},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1914347"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00933-8"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024850"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31366-0"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2406526"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709866"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-024-02392-7"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-024-03927-8"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-05778-2"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01951"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2315990121"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-024-02502-x"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-024-01068-2"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2308917"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(25)00159-6"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-024-00903-0"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.12.003"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.08.044"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00754-1"},{"key":"e_1_3_4_77_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-06-793141"},{"key":"e_1_3_4_78_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25010644"},{"key":"e_1_3_4_79_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0041-7"},{"key":"e_1_3_4_80_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-025-01498-6"},{"key":"e_1_3_4_81_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.20228"},{"key":"e_1_3_4_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.08.022"},{"key":"e_1_3_4_83_2","doi-asserted-by":"publisher","DOI":"10.3390\/cimb46050288"},{"key":"e_1_3_4_84_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003885"},{"key":"e_1_3_4_85_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1392831"},{"key":"e_1_3_4_86_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.03.006"},{"key":"e_1_3_4_87_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002394"},{"key":"e_1_3_4_88_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004162"},{"key":"e_1_3_4_89_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0737-3"},{"key":"e_1_3_4_90_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-02-769208"},{"key":"e_1_3_4_91_2","doi-asserted-by":"publisher","DOI":"10.1080\/1547691X.2024.2345158"},{"key":"e_1_3_4_92_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10766-5"},{"key":"e_1_3_4_93_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000952"},{"key":"e_1_3_4_94_2","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.21.26091"},{"key":"e_1_3_4_95_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2018-0028"},{"key":"e_1_3_4_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.03.019"},{"key":"e_1_3_4_97_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02404-6"},{"key":"e_1_3_4_98_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-05-846428"},{"issue":"20","key":"e_1_3_4_99_2","first-page":"2443","article-title":"How I treat unique and difficult to manage cases of CAR T-cell therapy associated neurotoxicity","volume":"141","author":"Santomasso BD","year":"2023","unstructured":"Santomasso BD, Gust J, Perna F. How I treat unique and difficult to manage cases of CAR T-cell therapy associated neurotoxicity. Blood 2023; 141(20): 2443\u20132451.","journal-title":"Blood"},{"key":"e_1_3_4_100_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000201083"},{"key":"e_1_3_4_101_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.09.037"},{"key":"e_1_3_4_102_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.02363"},{"key":"e_1_3_4_103_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2024.12.020"},{"issue":"4","key":"e_1_3_4_104_2","first-page":"312","article-title":"Cancer-related cognitive impairment in patients with hematologic malignancies after CAR T cell therapy: a systematic review and meta-analysis of prevalence","volume":"33","author":"Ho M-H","year":"2025","unstructured":"Ho M-H, Cheung DST, Wang T, et al. Cancer-related cognitive impairment in patients with hematologic malignancies after CAR T cell therapy: a systematic review and meta-analysis of prevalence. Support Care Cancer 2025; 33(4): 312.","journal-title":"Support Care Cancer"},{"key":"e_1_3_4_105_2","doi-asserted-by":"publisher","DOI":"10.3390\/biom13020382"},{"key":"e_1_3_4_106_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.03.006"},{"key":"e_1_3_4_107_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020010543"},{"key":"e_1_3_4_108_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01465-x"},{"key":"e_1_3_4_109_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-021-01526-0"},{"key":"e_1_3_4_110_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008066"},{"key":"e_1_3_4_111_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2021.10.037"},{"key":"e_1_3_4_112_2","doi-asserted-by":"publisher","DOI":"10.1111\/tid.14109"},{"key":"e_1_3_4_113_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.08.003"},{"key":"e_1_3_4_114_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025028375"},{"key":"e_1_3_4_115_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.799206"},{"key":"e_1_3_4_116_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-694356"},{"key":"e_1_3_4_117_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03084-6"},{"key":"e_1_3_4_118_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024015164"},{"key":"e_1_3_4_119_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2024.12.002"},{"key":"e_1_3_4_120_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024025945"},{"key":"e_1_3_4_121_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01564-7"},{"key":"e_1_3_4_122_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-1798"},{"key":"e_1_3_4_123_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-025-02605-7"},{"key":"e_1_3_4_124_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024024166"},{"key":"e_1_3_4_125_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004554"},{"key":"e_1_3_4_126_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2020.03.001"},{"key":"e_1_3_4_127_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-189503"},{"key":"e_1_3_4_128_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.13070"},{"key":"e_1_3_4_129_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2309728"},{"key":"e_1_3_4_130_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03458-w"},{"key":"e_1_3_4_131_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2408029"},{"key":"e_1_3_4_132_2","doi-asserted-by":"publisher","DOI":"10.1038\/s44321-024-00183-2"},{"key":"e_1_3_4_133_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(25)00091-8"},{"key":"e_1_3_4_134_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(25)00221-8"},{"issue":"19","key":"e_1_3_4_135_2","first-page":"2307","article-title":"5-Year follow-up supports curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1)","volume":"141","author":"Neelapu SS","year":"2023","unstructured":"Neelapu SS, Jacobson CA, Ghobadi A, et al. 5-Year follow-up supports curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1). Blood 2023; 141(19): 2307\u20132315.","journal-title":"Blood"},{"key":"e_1_3_4_136_2","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.87"},{"key":"e_1_3_4_137_2","doi-asserted-by":"publisher","DOI":"10.1002\/hem3.70070"},{"key":"e_1_3_4_138_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024012992"},{"key":"e_1_3_4_139_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00375-2"},{"key":"e_1_3_4_140_2","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.BCD-21-0084"},{"key":"e_1_3_4_141_2","unstructured":"European Medicines Agency. EudraLex\u2014Volume 4: good manufacturing practice (GMP) guidelines. European Commission https:\/\/health.ec.europa.eu\/medicinal-products\/eudralex\/eudralex-volume-4_en (2023 accessed 8 February 2025)."},{"key":"e_1_3_4_142_2","unstructured":"U.S. Food and Drug Administration. Current good manufacturing practice in manufacturing processing packing or holding of drugs. Electronic Code of Federal Regulations https:\/\/www.ecfr.gov\/current\/title-21\/chapter-I\/subchapter-C\/part-210 (2025 accessed 8 February 2025)."},{"key":"e_1_3_4_143_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102476"},{"key":"e_1_3_4_144_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2020.08.004"},{"key":"e_1_3_4_145_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-023-02086-1"},{"key":"e_1_3_4_146_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-1314"},{"key":"e_1_3_4_147_2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14215276"},{"key":"e_1_3_4_148_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2023.07.012"},{"key":"e_1_3_4_149_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-019-0643-y"},{"key":"e_1_3_4_150_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000600"},{"key":"e_1_3_4_151_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0010-1"},{"key":"e_1_3_4_152_2","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-20-1677"},{"key":"e_1_3_4_153_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04390-6"},{"key":"e_1_3_4_154_2","first-page":"492","volume-title":"Leukemia","volume":"30","author":"Sommermeyer D","year":"2016","unstructured":"Sommermeyer D, Hudecek M, Kosasih PL, et al. Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo. Leukemia 2016; 30(2): 492\u2013500."},{"key":"e_1_3_4_155_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101161"},{"key":"e_1_3_4_156_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.10.012"},{"key":"e_1_3_4_157_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01559-z"},{"key":"e_1_3_4_158_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024013656"},{"key":"e_1_3_4_159_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2022.02.007"},{"key":"e_1_3_4_160_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2024.09.007"},{"key":"e_1_3_4_161_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019002258"},{"key":"e_1_3_4_162_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0051-2"},{"key":"e_1_3_4_163_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(22)00245-9"},{"key":"e_1_3_4_164_2","doi-asserted-by":"publisher","DOI":"10.46989\/001c.116261"},{"key":"e_1_3_4_165_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-03-900928"},{"key":"e_1_3_4_166_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021006418"},{"key":"e_1_3_4_167_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1303935"},{"key":"e_1_3_4_168_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-023-00832-4"},{"key":"e_1_3_4_169_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015956"},{"key":"e_1_3_4_170_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.02.008"},{"key":"e_1_3_4_171_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022015526"},{"key":"e_1_3_4_172_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri1838"},{"key":"e_1_3_4_173_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI58743"},{"key":"e_1_3_4_174_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.30613"},{"key":"e_1_3_4_175_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11481-021-10004-9"},{"key":"e_1_3_4_176_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-021-01108-4"},{"key":"e_1_3_4_177_2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216863"},{"key":"e_1_3_4_178_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2025.06.029"},{"key":"e_1_3_4_179_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2025.06.042"},{"key":"e_1_3_4_180_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2025.06.2120"},{"key":"e_1_3_4_181_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2107725"},{"key":"e_1_3_4_182_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02017-5"},{"key":"e_1_3_4_183_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01126-1"},{"key":"e_1_3_4_184_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-024-05772-5"},{"key":"e_1_3_4_185_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2024.3818"},{"key":"e_1_3_4_186_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2016.18"},{"key":"e_1_3_4_187_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00721"},{"key":"e_1_3_4_188_2","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008525"},{"key":"e_1_3_4_189_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16266"},{"key":"e_1_3_4_190_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-90242-7.00014-6"},{"key":"e_1_3_4_191_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.ads8473"},{"key":"e_1_3_4_192_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.06.027"},{"key":"e_1_3_4_193_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2025.05.038"}],"container-title":["Therapeutic Advances in Neurological Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562864251396039","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/17562864251396039","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/17562864251396039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T17:34:11Z","timestamp":1769362451000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/17562864251396039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":192,"alternative-id":["10.1177\/17562864251396039"],"URL":"https:\/\/doi.org\/10.1177\/17562864251396039","relation":{},"ISSN":["1756-2864","1756-2864"],"issn-type":[{"value":"1756-2864","type":"print"},{"value":"1756-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"article-number":"17562864251396039"}}